DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 6, 2023
November 5, 2024
d738527c-0560-403a-b6a6-2a0d3055183f
Related Documents
Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy Guidance for Industry
Guidance DocumentSeptember 20, 2018Center for Drug Evaluation and Research
Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs: Guidance for Industry
Guidance DocumentDecember 7, 2023Center for Drug Evaluation and Research
Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier
Guidance DocumentSeptember 19, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox